Dominik Mumberg

Yeast vectors for the controlled expression of heterologous proteins in different genetic backgrounds

Dominik Mumberg, Rolf Müller, Martin Funk · Gene · 1995 · 2K citations

Life Sciences, Genetics, Molecular Biology +17

Regulatable promoters of Saccharomyces cerevisiae: comparison of transcriptional activity and their use for heterologous expression

Dominik Mumberg, Rolf Müller, Martin Funk · Nucleic Acids Research · 1994 · 975 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

CD4 ⁺ T cells eliminate MHC class II-negative cancer cells <i>in vivo</i> by indirect effects of IFN-γ

Dominik Mumberg, Paul A. Monach, Sherry Wanderling et al. · Proceedings of the National Academy of Sciences · 1999 · 383 citations

Life Sciences, Immunology, Oncology +17

BAY 80-6946 Is a Highly Selective Intravenous PI3K Inhibitor with Potent p110α and p110δ Activities in Tumor Cell Lines and Xenograft Models

Ningshu Liu, Bruce R. Rowley, Cathy Bull et al. · Molecular Cancer Therapeutics · 2013 · 256 citations

Medicine, Oncology, Pharmacology +15

The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage–Inducing or Repair–Compromising Therapies in Preclinical Cancer Models

Antje M. Wengner, Gerhard Siemeister, Ulrich Lücking et al. · Molecular Cancer Therapeutics · 2019 · 210 citations

Medicine, Molecular Biology, Oncology +17